GENINUS Inc. (KOSDAQ:389030)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
Medical Labs & Research	6.97B	10.08B
Medical Labs & Research Growth	-30.90%	-
Total	6.97B	10.08B
Total Growth	-30.90%	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec 31, 2023	Dec 31, 2022
South Korea	6.64B	9.82B
South Korea Growth	-32.34%	-
Asia	32.85M	21.85M
Asia Growth	50.38%	-
United States	290.97M	242.97M
United States Growth	19.75%	-
Total	6.97B	10.08B
Total Growth	-30.90%	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 30, 2026

Data Sources Report a data error